 - link Copy Url
- [  Share on twitter ](https://twitter.com/intent/tweet?text=Novo Nordisk’s Triple Bottom Line Yields Shared Value https://www.3blmedia.com/markdownify/node/27834?absolute=1&via=3blnews "link to 3 B L Media's Twitter")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/27834?absolute=1 "link to 3 B L Media's Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/27834?absolute=1 "link to 3 B L Media's Facebook")
- [ email Share via email ](mailto:?subject=Novo Nordisk’s Triple Bottom Line Yields Shared Value&body=ESG News from Novo Nordisk https://www.3blmedia.com/markdownify/node/27834?absolute=1 "Share via email")
 
 

 [Innovation &amp; Technology](/CSR-News/innovation-technology-0)

 # Novo Nordisk’s Triple Bottom Line Yields Shared Value

 

##### Assessing and communicating how a Triple Bottom Line business principle delivers value to business and society.

 

 

 Jun 1, 2012 3:00 PM ET

  

(3BL Media) June 1, 2012 - In the company’s fourth Blueprint for Change case study, Novo Nordisk provides evidence that its Triple Bottom Line business approach has resulted in higher quality and access to diabetes treatment in Bangladesh.

Since the launch of the Blueprint for Change Programme in 2010, Novo Nordisk has been building the evidence base for a Triple Bottom Line business approach that prioritises social, environmental and financial responsibility. The new Blueprint case study evaluates Novo Nordisk’s commercial business activities in Bangladesh and demonstrates how they have become drivers of shared value.

 

“Corporate sustainability is both values driven and business driven. Our aim with these case studies is to strengthen the business case for a Triple Bottom Line approach and inspire other companies,” says Ole Kjerkegaard Nielsen, programme director for the Blueprint for Change Programme.

The Blueprint for Change case study on Bangladesh concludes by stating the opportunities and challenges of using a similar Triple Bottom Line approach to address access in other least developed countries. Findings include the positive correlation between investing start-up capital in sustainable medical education programmes and the corresponding improvement in treatment outcomes and quality of care. Additionally, the case study highlights the shared value of a partnership approach, including improved accessibility and affordability of treatment, strengthened reputational value and increased sales volume.

Download the *[Blueprint for Change: Changing Diabetes in Bangladesh](http://novonordisk.com/images/Sustainability/PDFs/Blueprint%20for%20change%20-%20Bangladesh.pdf)*



 

**About the Blueprint for Change Programme**

The Novo Nordisk Blueprint for Change Programme aims to assess and communicate how a Triple Bottom Line business principle delivers value to business and society. Each of the four Blueprint for Change case studies present models of sustainable business practices and help identify key challenges ahead.

For more information, please visit: <http://novonordisk.com/sustainability/How-we-manage/blueprints.asp>

**About Sustainability at Novo Nordisk**

*Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2012, Novo Nordisk received the top ranking on Corporate Knight’s list of Global 100 Most Sustainable Corporations. Novo Nordisk is listed in the 2010/2011 Dow Jones Sustainability Indices with a gold class rating. For more information, visit [novonordisk.com/sustainability](http://novonordisk.com/sustainability)*

Further information:

Media

Charlotte Zarp-Andersson

Tel: (+45) 3079 7603

<czpa@novonordisk.com>

 

Blueprint for Change Programme

Ole Kjerkegaard Nielsen

Tel: (+45) 3079 2220

<okn@novonordisk.com>



 

 

 

 

 

 

 

 [![](/sites/default/files/Clients/NN_m_2c_RGB_small.png)](/profiles/novo-nordisk)

 



 

### More from Novo Nordisk

###### [How Do We Innovate Diabetes Care in Africa’s Biggest Country?](/news/how-do-we-innovate-diabetes-care-africas-biggest-country)

 Sep 29, 2016 10:00 AM ET

  



###### [Diabetes Campaign Launched in Nigeria to Promote Early Diagnosis ](/news/diabetes-campaign-launched-nigeria-promote-early-diagnosis)

 Sep 20, 2016 10:25 AM ET

  



###### [Novo Nordisk Improves Score, Remains at the Top of 2016 Dow Jones Sustainability Indices](/news/novo-nordisk-improves-score-remains-top-2016-dow-jones-sustainability-indices)

 Sep 12, 2016 10:40 AM ET

  



###### [Helicopter View of A Sustainable City](/news/helicopter-view-sustainable-city)

 Aug 22, 2016 1:05 PM ET

  



###### [Partnering with Diabetes At The Centre of the Universe](/news/partnering-diabetes-centre-universe)

 Aug 10, 2016 10:00 AM ET

  



###### [\#WeAreNotWaiting](/news/wearenotwaiting)

 Aug 5, 2016 9:00 AM ET

  



###### [The Digital Health Connection in Africa](/news/digital-health-connection-africa)

 Jul 21, 2016 9:00 AM ET

  



###### [Companies Have Unique Contributions to Bring to the Table](/news/companies-have-unique-contributions-bring-table)

 Jul 14, 2016 9:00 AM ET